Tuesday, November 14, 2017 10:32:06 AM
Really seems like only a matter of time until Novartis acquires Conatus. But is that a bitter pill to swallow since it was part of Novartis to begin with? Or is that just a BP strategy to look like they are geniuses? "Spin-off" something they know is going to succeed--let them fund themselves up to a certain stage so that "drain" isn't on your financials--but keep a monetary leash on it so you don't lose it to a competitor, then "acquire" it and look like you're making the smartest acquisitions for your investors. Anyone know of any precedent like that?
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM